Biotechnology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 35.
Computer-Designed Nano-Fibrous Scaffolds
Nano-fibrous scaffolding mimics aspects of the extracellular matrix to improve cell function and tissue formation. Although several methods exist to fabricate nano-fibrous scaffolds, the combination of phase separation with reverse solid freeform fabrication (SFF) allows for scaffolds with features at three different orders of magnitude to be formed, which is not easily achieved with other nano-fiber fabrication methods. This technique allows for the external shape and internal pore structure to be precisely controlled in an easily repeatable manner, while the nano-fibrous wall architecture facilitates cellular attachment,...
Source: Springer protocols feed by Biotechnology - April 30, 2012 Category: Biotechnology Source Type: news
A Neural Network Technique for Remeshing of Bone Microstructure
Today, there is major interest within the biomedical community in developing accurate noninvasive means for the evaluation of bone microstructure and bone quality. Recent improvements in 3D imaging technology, among them development of micro-CT and micro-MRI scanners, allow in-vivo 3D high-resolution scanning and reconstruction of large specimens or even whole bone models. Thus, the tendency today is to evaluate bone features using 3D assessment techniques rather than traditional 2D methods. For this purpose, high-quality meshing methods are required. However, the 3D meshes produced from current commercial systems usually ...
Source: Springer protocols feed by Biotechnology - April 30, 2012 Category: Biotechnology Source Type: news
Sartorius Stedim Biotech Launches Initiative To Enhance Supply Chain Security
Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, has substantially extended its supply chain security practices.
Source: Pharmaceutical Online News - April 30, 2012 Category: Pharmaceuticals Source Type: news
Competition doesn't always lead to cheaper drugs: DoP
The Department of Pharmaceuticals has told a group of ministers that competition does not necessarily lead to reduction in medicine prices.
Source: The Economic Times Healthcare and Biotech News - April 29, 2012 Category: Pharmaceuticals Source Type: news
Bioluminescent technology for easy tracking of GMO
(BioMed Central) New research published in BioMed Central's open access journal BMC Biotechnology shows that products from genetically modified crops can be identified at low concentration, using bioluminescent real time reporter technology and loop mediated isothermal amplification. The combination of these techniques was able to recognize 0.1 percent GM contamination of maize, far below the current EU limit of 0.9 percent.
Source: EurekAlert! - Biology - April 29, 2012 Category: Biology Source Type: news
Researchers Find Age-Related Gene Regulators
Researchers in the UK appear to have found a set of epigenetically regulated genes that influence aging. The study published in the on-line journal PLoS Genetics associated chemical modifications in DNA (i.e., epigenetic marks) with age and aging characteristics, such as lung function, bone mineral density, blood pressure, of 172 female identical twins between 32 and 80 years old. They found 490 genes with that had changes in epigenetic marks that correlated with the age, 4 that correlated with differences in age-related traits, specifically LDL cholesterol levels, lung function, and maternal longevity (mother's lifespan)....Read Full Post
Source: About.com Biotech Biomedical - April 28, 2012 Category: Biotechnology Source Type: news
Singularity University: meet the people who are building our future
Take top thinkers from Silicon Valley and science, mix them with scientists, innovators and philanthro-capitalists, and you've got the Singularity University – on a mission to seek technological solutions to the world's great challengesIt's day one at the Singularity University: the opening address has just been delivered by a hologram. Craig Venter, who was one of the first scientists to sequence the human genome and created the first synthetic life form, is up next. And later, we will see two people, paralysed from the waist down, use robotic exoskeletons to rise up and walk.But first, the co-founder of the Singularity...
Source: Guardian Unlimited Science - April 28, 2012 Category: Science Authors: Carole Cadwalladr Tags: Computing Robots Technology Google Internet Science Human Genome Project Genetics Biology University teaching Education Science fiction The Observer Features Source Type: news
Ten-Year Study Demonstrates Safety of Retroviral Gene Therapy Using T-Cells
Researchers at the University of Pennsylvania completed a 10-year long follow up gene therapy safety study of patients that received an engineered gene which enabled immune system T-cells to recognize the HIV virus. In three trials between 1998 and 2002, immune system T-cells from the blood of 43 HIV-positive patients were infected with an modified retrovirus carrying an engineered gene called CD3-zeta. As a result, the CD3-zeta gene, which combined parts of the natural CD3 and CD4 genes to enable it to recognize the HIV virus and turn on the T-cell's immune response, became part of the genomic DNA in the T-cells. The T-ce...
Source: About.com Biotech Biomedical - April 28, 2012 Category: Biotechnology Source Type: news
Whitehouse Releases Guidelines for the Bioeconomy
The White House just released a National Bioeconomy Blueprint which outlines initiatives and policies for Federal government agencies to advance and promote development of a broad range of biology-related industries from biofuels through environmental sciences. Of course, a large portion of the report the report focuses on the largest segment of the bioeconomy, biomedical research, and two of the six outlined objectives target the major challenges with bring developing and launching new drugs, diagnostic tests, and medical devices....Read Full Post
Source: About.com Biotech Biomedical - April 28, 2012 Category: Biotechnology Source Type: news
EVENT ANNOUNCEMENT: BioFlorida's 9th Celebration of Biotechnology
(BUSINESS WIRE)--Apr 27, 2012 - WHAT: The community is
invited to attend the 9th Annual Celebration of
Biotechnology on Thursday, May 10 from 9:30 a.m. until 1 p.m. on
the RTI Biologics campus in Progress Corporate Park, Alachua, Fla.
The outdoor...
Source: Drugs.com - Pharma News - April 27, 2012 Category: Pharmaceuticals Source Type: news
BIOTRONIK SE & Co. KG: BIOTRONIK Evia HF-T, World's First MRI-Approved CRT Pacemaker
BERLIN (MARKET WIRE) BIOTRONIK, a leading manufacturer of medical devices featuring innovative technology, announced today the European market release of the new Evia HF-T pacemaker series. Evia HF-T is the first cardiac resynchronization therapy (CRT-P) device approved for use in an MRI environment(1). In addition, the Evia HF-T series offers remote patient management with BIOTRONIK Home Monitoring(R), as well as detailed data available via BIOTRONIK's Heart Failure Monitor. This information allows for faster therapy intervention to relieve even asymptomatic symptoms earlier and may even help to decrease
Source: Market Wire - Pharmaceuticals and Biotech - April 27, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Cytori Therapeutics, Inc. : Cytori to Webcast First Quarter Financial Results May 9
SAN DIEGO, CA (MARKET WIRE) Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its first quarter financial results and business update on Wednesday, May 9, 2012 at 5:00 PM Eastern Time.
Source: Market Wire - Pharmaceuticals and Biotech - April 27, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare CYTX Source Type: news
NephroPlus to set up 40 kidney care clinics in North India
City-based NephroPlus, a kidney care clinics chain, will set up 40 of its proposed 100 dialysis centres in North India over the next three years.
Source: The Economic Times Healthcare and Biotech News - April 27, 2012 Category: Pharmaceuticals Source Type: news
Drugmakers give swine flu vaccines a second shot
Five Indian companies invested more than 1 billion rupees ($19 million) to develop vaccines but sold less than 400 million rupees worth.
Source: The Economic Times Healthcare and Biotech News - April 27, 2012 Category: Pharmaceuticals Source Type: news
New Drug Application for Arzerra Submitted in Japan
- New Drug Application for Arzerra submitted to Japanese regulatory authorities
COPENHAGEN, Denmark, April 27, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline (GSK) and Genmab A/S (Copenhagen:GEN) announced today the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare (MHLW) for Arzerra(R) (ofatumumab) for the treatment of chronic lymphocytic leukemia (CLL).
"This marks another important achievement in our collaboration with GSK for Arzerra," said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. "The global commercialization of Arzerra continues as planned."
Toda...
Source: Medical News (via PRIMEZONE) - April 27, 2012 Category: Pharmaceuticals Source Type: news
UAB researcher receives HudsonAlpha Prize
(HudsonAlpha Institute for Biotechnology) Tim Townes, Ph.D., University of Alabama at Birmingham, was awarded the HudsonAlpha Prize for his work on sickle cell and related blood disorders. The $20,000 monetary award acknowledges exceptional talent, dedication and discovery by Alabama's best and brightest researchers.
Source: EurekAlert! - Biology - April 27, 2012 Category: Biology Source Type: news
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
(Genomatix Software GmbH) Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer.
Source: EurekAlert! - Biology - April 27, 2012 Category: Biology Source Type: news
Strides Arcolab buys injectable unit Sterile Formulations
Strides Arcolab's wholly-owned subsidiary Agila Specialities acquired Sterile Formulations facility located at Hosur from Star Drugs and Research Labs.
Source: The Economic Times Healthcare and Biotech News - April 26, 2012 Category: Pharmaceuticals Source Type: news
Interphex 2012 – Innovative Process Solutions From The Brands You Trust
Quadro Engineering, Fitzpatrick Company and Microfluidics are teaming up at Interphex 2012 (May 1-3) in New York, New York in Booth # 1653 to exhibit solids and liquids processing solutions specifically designed for the pharmaceutical and biotechnology markets.
Source: Pharmaceutical Online News - April 26, 2012 Category: Pharmaceuticals Source Type: news
West Pharmaceutical Services, Inc.: West Announces First Quarter 2012 Results, Revises 2012 Guidance
LIONVILLE, PA (MARKET WIRE) West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2012.
Source: Market Wire - Pharmaceuticals and Biotech - April 26, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech WST Source Type: news
Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Reports 2011 Year End Results
TORONTO, ONTARIO (MARKET WIRE) Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") a life sciences development company of stem cell-related therapeutics, today reported its operational and financial results for the 2011 fiscal year, ended December 31.
Source: Market Wire - Pharmaceuticals and Biotech - April 26, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech SSS Source Type: news
TGen helps the Arizona Experience showcase the state's progress in Biotechnology and Life Sciences
Dr. Jeffrey Trent, President and Research Director of the Translational Genomic Research Institute (TGen), speaks about the role of genomics in improving...
Source: TGen News - April 26, 2012 Category: Genetics & Stem Cells Authors: TGEN Tags: Science News Source Type: news
Monsanto buys leading bee research firm after being implicated in bee colony collapse
Amid all the controversy over genetically-modified (GM) crops and their pesticides and herbicides decimating bee populations all around the world, biotechnology behemoth Monsanto has decided to buy out one of the major international firms devoted to studying and protecting...
Source: NaturalNews.com - April 26, 2012 Category: Consumer Health Advice Source Type: news
Roche Abandons Takeover of Illumina
Roche's $46.8 billion bid to take over Illumina fell through when Roche allowed it to expire last week after Illumina's shareholders rejected Roche's attempt to appoint its own directors to Illumina's board. Although Roche has been actively pursuing this deal since December last year and agreed to sweeten the offer from $44.50 per share in cash to $51.00 per in the end of March, Roche declined to pursue the company further after the latest rebuff....Read Full Post
Source: About.com Biotech Biomedical - April 26, 2012 Category: Biotechnology Source Type: news
Supreme Court's Ruling against Prometheus Shakes Up Personalized Medicine
The Supreme Court's unanimous ruling last month that a Prometheus Laboratories' patents on a PCR-based blood test that looks at variations of a particular gene to determine an individual's dosage for a particular drug were not valid created somewhat of a sensation in the biotech sphere. Prometheus, part of Nestle Health Science, sued the Mayo Clinic when the clinic substituted its own in-house developed procedure for the $260 test that Prometheus sold to determine a patient's starting dose of the drug thiopurine, which is often used to treat inflammatory bowel diseases such as Crohn's disease or ulcerative coliti...
Source: About.com Biotech Biomedical - April 25, 2012 Category: Biotechnology Source Type: news
Supreme Court's Ruling against Prometheus' Shakes Up Personalized Medicine
The Supreme Court's unanimous ruling last month that a Prometheus Laboratories' patents on a PCR-based blood test that looks at variations of a particular gene to determine an individual's dosage for a particular drug were not valid created somewhat of a sensation in the biotech sphere. Prometheus, part of Nestle Health Science, sued the Mayo Clinic when the clinic substituted its own in-house developed procedure for the $260 test that Prometheus sold to determine a patient's starting dose of the drug thiopurine, which is often used to treat inflammatory bowel diseases such as Crohn's disease or ulcerative coliti...
Source: About.com Biotech Biomedical - April 25, 2012 Category: Biotechnology Source Type: news
Amgen acquires majority stake in Turkey’s Mustafa Nevzat Pharmaceuticals
Biotechnology company Amgen has signed a deal to acquire 95.6% shares of Turkish firm Mustafa Nevzat Pharmaceuticals (MN) for $700 million.
Source: Pharmaceutical Technology - April 25, 2012 Category: Pharmaceuticals Source Type: news
Trenzyme-Recombinant Expression, Protein Purification and Mammalian Cell Line Development
Trenzyme is a privately owned German biotech company that offers highly individualised and modular services, from recombinant protein expression in different host systems like E. coli, yeast, Baculo-...
Source: Drug Development Technology - April 25, 2012 Category: Pharmaceuticals Source Type: news
ChrysCap to buy Rs 300-cr stake in Intas Pharma
Private equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug maker deferred its IPO due to volatile market conditions.
Source: The Economic Times Healthcare and Biotech News - April 25, 2012 Category: Pharmaceuticals Source Type: news
ChrysCap to buy Rs 300-cr stake in Intas Pharmaceuticals
Private equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug maker deferred its IPO due to volatile market conditions.
Source: The Economic Times Healthcare and Biotech News - April 25, 2012 Category: Pharmaceuticals Source Type: news
Amgen snaps up Turkish generic drug group
Biotech company steps up shift into off-patent medicines and emerging markets with $700m deal for control of Mustafa Nevzat Pharmaceuticals
Source: FT.com - Drugs and Healthcare - April 25, 2012 Category: Pharmaceuticals Source Type: news
Passive and Electrically Actuated Solid-State Nanopores for Sensing and Manipulating DNA
Solid-state nanopores have emerged as powerful new tools for electrically characterizing single DNA molecules. When DNA molecules are made to rapidly translocate a nanopore by electrophoresis, the resulting ionic current blockage provides information about the molecular length and folding conformation. A solid-state nanopore can also be integrated with nanofabricated actuators and sensors, such as an embedded gate electrode or transverse tunneling electrodes, to enhance its functionality. Here we describe detailed methods for fabricating passive solid-state nanopores and using them to detect DNA translocations. We also des...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Measuring Single-Wall Carbon Nanotubes with Solid-State Nanopores
Solid-state nanopores have been used widely to study biological polymers. Here, we expand the technique to analyze single-wall carbon nanotubes. By wrapping them in an amphiphilic layer, individual tubes can be translocated electrically through a nanopore, resulting in temporary interruptions in the trans-pore current reminiscent of measurements on DNA, RNA, and proteins. The technique may find use in discriminating nanotubes by size and thus electrical structure, facilitating their inclusion in electrical devices.
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Graphene Nanopore Devices for DNA Sensing
We describe here a method for detecting the translocation of individual DNA molecules through nanopores created in graphene membranes. The devices consist of 1–5-nm thick graphene membranes with electron-beam sculpted nanopores from 5 to 10 nm in diameter. Due to the thin nature of the graphene membranes, and the reduced electrical resistance, we observe larger blocked currents than for traditional solid-state nanopores. We also show how ionic current noise levels can be reduced with the atomic-layer deposition of a few nanometers of titanium dioxide over the graphene surface. Unlike traditional solid-state nanopore ...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
DNA Characterization by Transverse Electrical Current in a Nanochannel
We describe the theoretical methods used to demonstrate this method for experimentally realizable systems and discuss the different physical processes involved. Recent experimental reports have shown the validity of this approach, although further work is necessary to make this a practical fast sequencing tool.
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Polymer Translocation Through an Electrically Tunable Nanopore in a Multilayered Semiconductor Membrane
We have developed a two-level computational model that enables us to calculate electrostatic fields created by a semiconductor membrane submerged in electrolytic solution and investigate the effects of these fields on the dynamics of a polymer translocating through a nanopore in the membrane. In order to calculate the electrostatic potentials and the ionic concentrations in a solid-state nanopore, we have self-consistently solved Poisson equation within the semiclassical approximation for charge carrier statistics in the membrane and electrolyte. The electrostatic potentials obtained from these simulations are then used in...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Optimization of the Molecular Dynamics Method for Simulations of DNA and Ion Transport Through Biological Nanopores
Molecular dynamics (MD) simulations have become a standard method for the rational design and interpretation of experimental studies of DNA translocation through nanopores. The MD method, however, offers a multitude of algorithms, parameters, and other protocol choices that can affect the accuracy of the resulting data as well as computational efficiency. In this chapter, we examine the most popular choices offered by the MD method, seeking an optimal set of parameters that enable the most computationally efficient and accurate simulations of DNA and ion transport through biological nanopores. In particular, we examine the...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Analyzing Single DNA Molecules by Nanopore Translocation
Small holes in membranes or nanocapillaries can be employed to detect single molecules in solution. In fact, the resistive-pulse technique based on nanopores allows for determination of length, charge, and folding state of deoxyribonucleic acid (DNA). Here, we describe the experimental procedures necessary for measuring single DNA molecules in nanocapillaries. We also discuss the measures for data analysis and how to determine that only single molecule events are observed.
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Optical Tweezers for Mechanical Control Over DNA in a Nanopore
The translocation of long-chain molecules, such as DNA or peptides, through membranes is an integral process for the function of living cells. During the translocation process, a number of interactions of electrostatic or hydrophobic nature govern the translocation velocity. Most of these interactions remain largely unexplored on the single-molecule level due to a lack of suitable instrumentation. We have shown that a combination of optical tweezers, single solid-state nanopores, and electrophysiological ionic current detection can provide further insight into the behavior of polymers in confinement. Here, we describe the ...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
DNA Sequencing by Nanopore-Induced Photon Emission
Nanopore-based DNA analysis is an extremely attractive area of research due to the simplicity of the method, and the ability to not only probe individual molecules, but also to detect very small amounts of genomic material. Here, we describe the materials and methods of a novel, nanopore-based, single-molecule DNA sequencing system that utilizes optical detection. We convert target DNA according to a binary code, which is recognized by molecular beacons with two types of fluorophores. Solid-state nanopores are then used to sequentially strip off the beacons, leading to a series of photon bursts that can be detected with a ...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
DNA Characterization with Ion Beam-Sculpted Silicon Nitride Nanopores
Solid-state nanopores are emerging as robust single molecule electronic measurement devices and as platforms for confining biomolecules for further analysis. The first silicon nitride nanopore to detect individual DNA molecules was fabricated using ion beam sculpting (IBS), a method that uses broad, low-energy ion beams to create nanopores with dimensions ranging from 2 to 20 nm. In this chapter, we discuss the fabrication, characterization, and use of IBS-sculpted nanopores as well as efficient uses of pClamp and MATLAB software suites for data acquisition and analysis. The fabrication section covers the repeatability and...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
DNA Unzipping and Protein Unfolding Using Nanopores
We present here an overview on unfolding of biomolecular structures as DNA double strands or protein folds. After some theoretical considerations giving orders of magnitude about transport timescales through pores, forces involved in unzipping processes … we present our experiments on DNA unzipping or protein unfolding using a nanopore. We point out the difficulties that can be encountered during these experiments, such as the signal analysis problems, noise issues, or experimental limitations of such system.
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Measurements of DNA Immobilized in the Alpha-Hemolysin Nanopore
In the past decade, there have been extensive studies aimed at exploring the potential of protein nanopores to sequence single strands of DNA using resistive pulse sensing. The high speed of DNA electrophoretically driven through these pores (∼l μs/base) necessitates high bandwidth measurements, which prevent resolution of the picoampere differences in blockage current resulting from different nucleotides. Here, we describe a procedure for the immobilization of DNA in the α-hemolysin protein nanopore which enables low-noise, high-precision measurements capable of resolving subpicoampere differences in blockage...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Protein Sensing with Engineered Protein Nanopores
The use of nanopores is a powerful new frontier in single-molecule sciences. Nanopores have been used effectively in exploring various biophysical features of small polypeptides and proteins, such as their folding state and structure, ligand interactions, and enzymatic activity. In particular, the α-hemolysin (αHL) protein pore has been used extensively for the detection, characterization, and analysis of polypeptides because this protein nanopore is highly robust, versatile, and tractable under various experimental conditions. Inspired by the mechanisms of protein translocation across the outer membrane transl...
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Detecting and Characterizing Individual Molecules with Single Nanopores
We describe herein some of our methods and approaches to address this issue.
Source: Springer protocols feed by Biotechnology - April 25, 2012 Category: Biotechnology Source Type: news
Ranbaxy to launch country's first 'made in India' drug
The antimalaria drug, a combination of two molecules -- arterolane maleate and piperaquine phosphatethe -- is expected to be priced at a significant discount, as low as one third, to some alternatives.
Source: The Economic Times Healthcare and Biotech News - April 25, 2012 Category: Pharmaceuticals Source Type: news
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Acquisition Will Build on Amgen’s Existing Business and Provide a Platform for Growth in Turkey and This Strategically Important Region
THOUSAND OAKS, Calif. and ISTANBUL, April 25, 2012 /PRNewswire via COMTEX/ --Amgen (NASDAQ:AMGN), the world’s largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million. The all-cash transaction will significantly expand Amgen’s presence in Turkey and the surrounding region, which a...
Source: Amgen News Service - April 25, 2012 Category: Pharmaceuticals Authors: pmannle at amgen.com Tags: Press Releases Source Type: news
ProMetic Signs A $1.4M Agreement With European Biotech Company
ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic" or the "Corporation") announced today the signing of an agreement by ProMetic's UK subsidiary, ProMetic Biosciences Ltd ("PBL") with a European biotechnology manufacturing company.
Source: Pharmaceutical Online News - April 25, 2012 Category: Pharmaceuticals Source Type: news
GoM on drug pricing to meet today
A panel of ministers will meet on Wednesday to discuss the formula to cap the retail prices of 348 essential drugs and their combinations.
Source: The Economic Times Healthcare and Biotech News - April 24, 2012 Category: Pharmaceuticals Source Type: news
